IL123093A0 - Pharmaceutical compositions containing 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers - Google Patents
Pharmaceutical compositions containing 1h-1,2,4-triazole derivatives for inhibiting the growth of cancersInfo
- Publication number
- IL123093A0 IL123093A0 IL12309396A IL12309396A IL123093A0 IL 123093 A0 IL123093 A0 IL 123093A0 IL 12309396 A IL12309396 A IL 12309396A IL 12309396 A IL12309396 A IL 12309396A IL 123093 A0 IL123093 A0 IL 123093A0
- Authority
- IL
- Israel
- Prior art keywords
- cancers
- inhibiting
- growth
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US183895P | 1995-08-03 | 1995-08-03 | |
| US08/674,182 US6200992B1 (en) | 1995-06-07 | 1996-07-16 | Pharmaceutical composition for inhibiting the growth of cancers |
| PCT/US1996/012473 WO1997005872A2 (en) | 1995-08-03 | 1996-07-30 | Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL123093A0 true IL123093A0 (en) | 1998-09-24 |
Family
ID=26669546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12309396A IL123093A0 (en) | 1995-08-03 | 1996-07-30 | Pharmaceutical compositions containing 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US6200992B1 (ko) |
| EP (1) | EP0841920A2 (ko) |
| JP (1) | JPH11510186A (ko) |
| KR (1) | KR19990036136A (ko) |
| CN (1) | CN1192142A (ko) |
| AR (1) | AR003174A1 (ko) |
| AU (1) | AU709007B2 (ko) |
| BR (1) | BR9609987A (ko) |
| CA (1) | CA2228502A1 (ko) |
| CZ (1) | CZ30698A3 (ko) |
| IL (1) | IL123093A0 (ko) |
| MX (1) | MX9800944A (ko) |
| NO (1) | NO980419L (ko) |
| PL (1) | PL324888A1 (ko) |
| SK (1) | SK14098A3 (ko) |
| TR (1) | TR199800245T2 (ko) |
| WO (1) | WO1997005872A2 (ko) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
| US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
| US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
| US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
| US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
| US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
| US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
| US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
| US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
| US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
| US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6608096B1 (en) * | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6462062B1 (en) * | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| AU2002214649A1 (en) * | 2000-10-16 | 2002-04-29 | Neopharm, Inc. | Liposomal formulation of mitoxantrone |
| CN1311872C (zh) * | 2004-12-29 | 2007-04-25 | 山东蓝金生物工程有限公司 | 一种抗癌药物组合物 |
| US8722014B2 (en) | 2009-05-01 | 2014-05-13 | Washington University | 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof |
| CN102532159B (zh) * | 2010-11-12 | 2015-02-11 | 姚雪彪 | 动点马达蛋白CENP-E小分子抑制剂Syntelin |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4079062A (en) | 1974-11-18 | 1978-03-14 | Janssen Pharmaceutica N.V. | Triazole derivatives |
| US4160838A (en) | 1977-06-02 | 1979-07-10 | Janssen Pharmaceutica N.V. | Antimicrobial and plant-growth-regulating triazole derivatives |
| GB2078719B (en) | 1980-06-02 | 1984-04-26 | Ici Ltd | Heterocyclic compounds |
| DE3262386D1 (en) | 1981-06-06 | 1985-03-28 | Pfizer Ltd | Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them |
| US4490540A (en) | 1981-09-14 | 1984-12-25 | Janssen Pharmaceutica N.V. | (2-Aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivatives |
| EP0196855A3 (en) | 1985-03-29 | 1989-04-12 | Pfizer Inc. | Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections |
| US5211736A (en) | 1988-05-09 | 1993-05-18 | Uniroyal Chemical Company, Inc. | Azole derivatives of spiroheterocycles |
| DE3837463A1 (de) | 1988-11-04 | 1990-05-10 | Bayer Ag | Substituierte bisazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US5114951A (en) | 1989-04-11 | 1992-05-19 | Burroughs Wellcome Company | Agents for combating multiple drug resistance |
| BE1004029A6 (nl) | 1990-11-22 | 1992-09-08 | Mol Omer De | Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker. |
| US5360612A (en) | 1992-10-13 | 1994-11-01 | Pfizer Inc. | Pharmaceutical compositions containing triazole derivatives for rectal administration |
| US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
-
1996
- 1996-07-16 US US08/674,182 patent/US6200992B1/en not_active Expired - Fee Related
- 1996-07-30 IL IL12309396A patent/IL123093A0/xx unknown
- 1996-07-30 CZ CZ98306A patent/CZ30698A3/cs unknown
- 1996-07-30 CA CA002228502A patent/CA2228502A1/en not_active Abandoned
- 1996-07-30 MX MX9800944A patent/MX9800944A/es not_active Application Discontinuation
- 1996-07-30 WO PCT/US1996/012473 patent/WO1997005872A2/en not_active Application Discontinuation
- 1996-07-30 CN CN96196038A patent/CN1192142A/zh active Pending
- 1996-07-30 PL PL96324888A patent/PL324888A1/xx unknown
- 1996-07-30 SK SK140-98A patent/SK14098A3/sk unknown
- 1996-07-30 TR TR1998/00245T patent/TR199800245T2/xx unknown
- 1996-07-30 EP EP96926805A patent/EP0841920A2/en not_active Ceased
- 1996-07-30 JP JP9508493A patent/JPH11510186A/ja active Pending
- 1996-07-30 AU AU66832/96A patent/AU709007B2/en not_active Ceased
- 1996-07-30 KR KR1019980700804A patent/KR19990036136A/ko not_active Application Discontinuation
- 1996-07-30 BR BR9609987A patent/BR9609987A/pt not_active Application Discontinuation
- 1996-08-02 AR ARP960103859A patent/AR003174A1/es unknown
-
1998
- 1998-01-30 NO NO980419A patent/NO980419L/no not_active Application Discontinuation
-
1999
- 1999-02-05 US US09/245,520 patent/US6110953A/en not_active Expired - Fee Related
-
2000
- 2000-12-15 US US09/737,835 patent/US20010047015A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2228502A1 (en) | 1997-02-20 |
| WO1997005872A2 (en) | 1997-02-20 |
| NO980419L (no) | 1998-04-02 |
| KR19990036136A (ko) | 1999-05-25 |
| EP0841920A2 (en) | 1998-05-20 |
| US6200992B1 (en) | 2001-03-13 |
| NO980419D0 (no) | 1998-01-30 |
| MX9800944A (es) | 1998-04-30 |
| AR003174A1 (es) | 1998-07-08 |
| PL324888A1 (en) | 1998-06-22 |
| AU709007B2 (en) | 1999-08-19 |
| SK14098A3 (en) | 1998-09-09 |
| BR9609987A (pt) | 1999-01-12 |
| WO1997005872A3 (en) | 1997-03-27 |
| TR199800245T2 (xx) | 1998-10-21 |
| AU6683296A (en) | 1997-03-05 |
| CN1192142A (zh) | 1998-09-02 |
| US20010047015A1 (en) | 2001-11-29 |
| JPH11510186A (ja) | 1999-09-07 |
| US6110953A (en) | 2000-08-29 |
| CZ30698A3 (cs) | 1998-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL123093A0 (en) | Pharmaceutical compositions containing 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers | |
| HUT74098A (en) | Imidazole and triazole derivatives having antifungal activiti, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| IL116455A0 (en) | Imidazole compounds and pharmaceutical compositions containing them | |
| HUP9801532A3 (en) | Use of benzimidazole derivatives for producing pharmaceutical compositions for inhibiting the growth of cancers | |
| HUT56361A (en) | Process for producing new triazole derivatives and pharmaceutical compositions comprising such compounds | |
| HUP9900625A3 (en) | Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds | |
| HUP9802629A3 (en) | Use of 1,3-bis(1,2,4-triazolyl)propan-2-ol derivatives for the manufacture of pharmaceutical compositions treating cancers | |
| AU4419193A (en) | Synthesis of 1,4,7-triazacyclononane derivatives | |
| HUP9901159A3 (en) | Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds | |
| HUP9900645A3 (en) | Novel substituted imidazole compounds, pharmaceutical compositions containing them and process for their producing | |
| IL123095A0 (en) | Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers | |
| EP0811595A4 (en) | HYDROCHALCONE DERIVATIVES, COSMETIC COMPOSITIONS CONTAINING THEM AND PROCESSES FOR PREPARING SUCH DERIVATIVES OR COMPOSITIONS | |
| IL118425A0 (en) | Pharmaceutical composition containing 1H-1,2,4-triazole derivative | |
| HUP0002050A3 (en) | Substituted imidazole compounds, process for producing them, pharmaceutical compositions containing them and their use | |
| ZA962916B (en) | New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds | |
| IL123094A0 (en) | Pharmaceutical compositions containing griseofulvin for inhibiting the growth of cancers | |
| HUP9801534A3 (en) | The use of n-chlorophenylcarbamates, and n-phosphonoglycine derivatives for producing pharmaceutical compositions wich are inhibiting the growth of cancers and viruses | |
| AU1642892A (en) | Process for the preparation of 1,4-dioxane-2,5-diones | |
| IL104471A0 (en) | Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP9801056A3 (en) | Triazolones as apolipoprotein-b synthesis inhibitors, process for producing them, their use and pharmaceutical compositions containing the same | |
| HUT66391A (en) | Fungicidal (2-aryl-2-substituted)-ethyl-1,2,4-triazole derivatives | |
| HUP9903555A3 (en) | Pharmaceutical compositions for inhibiting the growth of cancers containing 1h-1,2,4-triazole derivatives and a chemoterapeutic agent, and the use of the same | |
| HUP9600061A3 (en) | 3-alkoxycarbonyl-1,3,4-thiadiazin-2-on derivatives, process for their preparation and pharmaceutical compositions containing the same | |
| LT95072A (en) | Process for the preparation of 1,2,4-triazole sodium salt | |
| AU2701092A (en) | Pharmaceutical compositions containing triazole derivatives for rectal administration |